Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$501M |
| 2 |
UnitedHealth
UNH
|
+$307M |
| 3 |
Global Payments
GPN
|
+$302M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$279M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$238M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$433M |
| 2 |
Lam Research
LRCX
|
+$373M |
| 3 |
Pfizer
PFE
|
+$354M |
| 4 |
Verizon
VZ
|
+$341M |
| 5 |
EA
Electronic Arts
EA
|
+$305M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.18% |
| 2 | Healthcare | 10.69% |
| 3 | Financials | 10.58% |
| 4 | Industrials | 8.45% |
| 5 | Consumer Discretionary | 7.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3726
Ocular Therapeutix
OCUL
$2.14B
| $102K | ﹤0.01% |
32,610
+2,605
| +9% | +$10.7K |
|
|
SAND
3727
DELISTED
Sandstorm Gold
SAND
| $101K | ﹤0.01% |
21,769
-22,012
| -50% | -$116K |
|
|
CONN
3728
DELISTED
Conn's Inc.
CONN
| $101K | ﹤0.01% |
25,631
+4,872
| +23% | +$20.2K |
|
3729
Hudbay
HBM
$12.3B
| $99.6K | ﹤0.01% |
20,461
| – | – |
|
3730
Santander
BSBR
$43.1B
| $98.2K | ﹤0.01% |
19,141
-3,224
| -14% | -$18.3K |
|
3731
Mizuho Financial
MFG
$127B
| $96.3K | ﹤0.01% |
28,071
+11,243
| +67% | +$37.4K |
|
|
TEAD
3732
Teads Holding Co
TEAD
$65.6M
| $93.2K | ﹤0.01% |
19,134
-23,100
| -55% | -$122K |
|
|
DHY
3733
Credit Suisse High Yield Credit Fund
DHY
$242M
| $92.5K | ﹤0.01% |
49,201
-5,282
| -10% | -$9.98K |
|
3734
Peloton Interactive
PTON
$2.46B
| $92.2K | ﹤0.01% |
18,248
+2,464
| +16% | +$17.5K |
|
3735
CEMIG Preferred Shares
CIG
$5.64B
| $90.4K | ﹤0.01% |
48,491
| – | – |
|
3736
Rush Street Interactive
RSI
$2.91B
| $90.2K | ﹤0.01% |
19,527
| – | – |
|
3737
Eldorado Gold
EGO
$10.2B
| $89.4K | ﹤0.01% |
10,033
-800
| -7% | -$7.79K |
|
3738
SkinHealth Systems
SKIN
$91.1M
| $87.7K | ﹤0.01% |
+14,573
| New | +$102K |
|
|
NGM
3739
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $87.1K | ﹤0.01% |
81,411
| – | – |
|
3740
EyePoint Inc
EYPT
$1.13B
| $82.7K | ﹤0.01% |
+10,349
| New | +$113K |
|
|
SVM
3741
Silvercorp Metals
SVM
$2.79B
| $82.2K | ﹤0.01% |
34,975
-2,196
| -6% | -$5.96K |
|
|
MTTR
3742
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
| $81.5K | ﹤0.01% |
37,579
-10,808
| -22% | -$30.3K |
|
|
TE
3743
T1 Energy
TE
$1.53B
| $79.7K | ﹤0.01% |
16,300
+5,218
| +47% | +$37.5K |
|
|
PGRE
3744
DELISTED
Paramount Group
PGRE
| $77.4K | ﹤0.01% |
16,625
-573
| -3% | -$2.83K |
|
|
BKCC
3745
DELISTED
BlackRock Capital Investment Corporation
BKCC
| $76.4K | ﹤0.01% |
20,601
-8,022
| -28% | -$28.8K |
|
|
OPI
3746
DELISTED
Office Properties Income Trust
OPI
| $75.6K | ﹤0.01% |
18,435
-247,850
| -93% | -$1.72M |
|
|
SJT
3747
San Juan Basin Royalty Trust
SJT
$126M
| $75.3K | ﹤0.01% |
10,859
+400
| +4% | +$2.88K |
|
3748
Energy Vault
NRGV
$649M
| $74.5K | ﹤0.01% |
29,210
+3,010
| +11% | +$9.01K |
|
3749
Ambev
ABEV
$43.9B
| $74.4K | ﹤0.01% |
28,822
-668
| -2% | -$1.93K |
|
3750
Clean Energy Fuels
CLNE
$377M
| $73.5K | ﹤0.01% |
19,195
+1,344
| +8% | +$5.99K |
|
Similar funds
Ameriprise's Q3 2023 Portfolio in Review
As of Q3 2023, Ameriprise held 4,031 positions worth $305B, down 4.5% from $319B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Ameriprise's Q3 2023 filing shows 127 new, 1,527 increased, 2,081 reduced and 148 closed positions. Its largest new stake was TKO Group: 772,651 shares worth $64.9M. The largest sale was Johnson & Johnson, an estimated $433M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Ameriprise's largest Q3 2023 buy was TKO Group: 772,651 shares worth $64.9M.
- Ameriprise added most to AT&T in Q3 2023, an estimated $501M increase.
- Ameriprise's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $433M.
- Ameriprise fully exited NiSource Inc. Series A Corporate Units in Q3 2023, selling an estimated $73.8M.
- Ameriprise's ten largest holdings make up 16% of its $305B portfolio in Q3 2023.
- Ameriprise opened 127 new positions and closed 148 in Q3 2023.
- Ameriprise's portfolio value fell 4.5% quarter-over-quarter to $305B.
Based on Ameriprise's 13F filing for Q3 2023, filed 14 Nov 2023.